Application of Pro-angiogenic Biomaterials in Myocardial Infarction

Biomaterials have potential applications in the treatment of myocardial infarction (MI). These biomaterials have the ability to mechanically support the ventricular wall and to modulate the inflammatory, metabolic, and local electrophysiological microenvironment. In addition, they can play an equall...

Full description

Saved in:
Bibliographic Details
Published in:ACS omega 2024-09, Vol.9 (36), p.37505-37529
Main Authors: Liang, Tingting, Liu, Jun, Liu, Feila, Su, Xiaohan, Li, Xue, Zeng, Jiao, Chen, Fuli, Wen, Heling, Chen, Yu, Tao, Jianhong, Lei, Qian, Li, Gang, Cheng, Panke
Format: Article
Language:English
Subjects:
Review
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-a383t-2867966c8e55bf6a8a0ed2906c8ed33449895a800b3c92af19b25654514f101c3
container_end_page 37529
container_issue 36
container_start_page 37505
container_title ACS omega
container_volume 9
creator Liang, Tingting
Liu, Jun
Liu, Feila
Su, Xiaohan
Li, Xue
Zeng, Jiao
Chen, Fuli
Wen, Heling
Chen, Yu
Tao, Jianhong
Lei, Qian
Li, Gang
Cheng, Panke
description Biomaterials have potential applications in the treatment of myocardial infarction (MI). These biomaterials have the ability to mechanically support the ventricular wall and to modulate the inflammatory, metabolic, and local electrophysiological microenvironment. In addition, they can play an equally important role in promoting angiogenesis, which is the primary prerequisite for the treatment of MI. A variety of biomaterials are known to exert pro-angiogenic effects, but the pro-angiogenic mechanisms and functions of different biomaterials are complex and diverse, and have not yet been systematically described. This review will focus on the pro-angiogenesis of biomaterials and systematically describe the mechanisms and functions of different biomaterials in promoting angiogenesis in MI.
doi_str_mv 10.1021/acsomega.4c04682
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_ee8d3c1c57ab46a28467e81a379a2dfb</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_ee8d3c1c57ab46a28467e81a379a2dfb</doaj_id><sourcerecordid>3106038765</sourcerecordid><originalsourceid>FETCH-LOGICAL-a383t-2867966c8e55bf6a8a0ed2906c8ed33449895a800b3c92af19b25654514f101c3</originalsourceid><addsrcrecordid>eNp1kc1P3DAQxa2KqiDg3hPKkQOh_o59QnRF25VA5UDP1sRxgleJvbWzSPz3eLsLgkNPtmfe-83ID6GvBF8STMk3sDlOboBLbjGXin5CR5Q3uCaMs4N390N0mvMKY0yKSFH5BR0yTRXRnB-hxfV6PXoLs4-hin11n2INYfBxcMHb6ruPE8wueRhz5UN19xwtpK48q2XoIdmt7wR97kvfne7PY_Tnx83D4ld9-_vncnF9WwNTbK6pko2W0ionRNtLUIBdRzXeVjrGONdKC1AYt8xqCj3RLRVScEF4TzCx7Bgtd9wuwsqsk58gPZsI3vwrxDQYSLO3ozPOqY5ZYkUDLZdAFZeNUwRYo4F2fVtYVzvWetNOrrMuzAnGD9CPneAfzRCfDCFMEyF1IZzvCSn-3bg8m8ln68YRgoubbBjBEjPVSFGkeCe1KeacXP82h2CzzdK8Zmn2WRbL2fv93gyvyRXBxU5QrGYVNymUr_8_7wUom6rE</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3106038765</pqid></control><display><type>article</type><title>Application of Pro-angiogenic Biomaterials in Myocardial Infarction</title><source>American Chemical Society (ACS) Open Access</source><source>PubMed Central</source><creator>Liang, Tingting ; Liu, Jun ; Liu, Feila ; Su, Xiaohan ; Li, Xue ; Zeng, Jiao ; Chen, Fuli ; Wen, Heling ; Chen, Yu ; Tao, Jianhong ; Lei, Qian ; Li, Gang ; Cheng, Panke</creator><creatorcontrib>Liang, Tingting ; Liu, Jun ; Liu, Feila ; Su, Xiaohan ; Li, Xue ; Zeng, Jiao ; Chen, Fuli ; Wen, Heling ; Chen, Yu ; Tao, Jianhong ; Lei, Qian ; Li, Gang ; Cheng, Panke</creatorcontrib><description>Biomaterials have potential applications in the treatment of myocardial infarction (MI). These biomaterials have the ability to mechanically support the ventricular wall and to modulate the inflammatory, metabolic, and local electrophysiological microenvironment. In addition, they can play an equally important role in promoting angiogenesis, which is the primary prerequisite for the treatment of MI. A variety of biomaterials are known to exert pro-angiogenic effects, but the pro-angiogenic mechanisms and functions of different biomaterials are complex and diverse, and have not yet been systematically described. This review will focus on the pro-angiogenesis of biomaterials and systematically describe the mechanisms and functions of different biomaterials in promoting angiogenesis in MI.</description><identifier>ISSN: 2470-1343</identifier><identifier>EISSN: 2470-1343</identifier><identifier>DOI: 10.1021/acsomega.4c04682</identifier><identifier>PMID: 39281944</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Review</subject><ispartof>ACS omega, 2024-09, Vol.9 (36), p.37505-37529</ispartof><rights>2024 The Authors. Published by American Chemical Society</rights><rights>2024 The Authors. Published by American Chemical Society.</rights><rights>2024 The Authors. Published by American Chemical Society 2024 The Authors</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-a383t-2867966c8e55bf6a8a0ed2906c8ed33449895a800b3c92af19b25654514f101c3</cites><orcidid>0000-0002-1900-8358</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/acsomega.4c04682$$EPDF$$P50$$Gacs$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/acsomega.4c04682$$EHTML$$P50$$Gacs$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,882,27061,27905,27906,53772,53774,56743,56793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39281944$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Liang, Tingting</creatorcontrib><creatorcontrib>Liu, Jun</creatorcontrib><creatorcontrib>Liu, Feila</creatorcontrib><creatorcontrib>Su, Xiaohan</creatorcontrib><creatorcontrib>Li, Xue</creatorcontrib><creatorcontrib>Zeng, Jiao</creatorcontrib><creatorcontrib>Chen, Fuli</creatorcontrib><creatorcontrib>Wen, Heling</creatorcontrib><creatorcontrib>Chen, Yu</creatorcontrib><creatorcontrib>Tao, Jianhong</creatorcontrib><creatorcontrib>Lei, Qian</creatorcontrib><creatorcontrib>Li, Gang</creatorcontrib><creatorcontrib>Cheng, Panke</creatorcontrib><title>Application of Pro-angiogenic Biomaterials in Myocardial Infarction</title><title>ACS omega</title><addtitle>ACS Omega</addtitle><description>Biomaterials have potential applications in the treatment of myocardial infarction (MI). These biomaterials have the ability to mechanically support the ventricular wall and to modulate the inflammatory, metabolic, and local electrophysiological microenvironment. In addition, they can play an equally important role in promoting angiogenesis, which is the primary prerequisite for the treatment of MI. A variety of biomaterials are known to exert pro-angiogenic effects, but the pro-angiogenic mechanisms and functions of different biomaterials are complex and diverse, and have not yet been systematically described. This review will focus on the pro-angiogenesis of biomaterials and systematically describe the mechanisms and functions of different biomaterials in promoting angiogenesis in MI.</description><subject>Review</subject><issn>2470-1343</issn><issn>2470-1343</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>N~.</sourceid><sourceid>DOA</sourceid><recordid>eNp1kc1P3DAQxa2KqiDg3hPKkQOh_o59QnRF25VA5UDP1sRxgleJvbWzSPz3eLsLgkNPtmfe-83ID6GvBF8STMk3sDlOboBLbjGXin5CR5Q3uCaMs4N390N0mvMKY0yKSFH5BR0yTRXRnB-hxfV6PXoLs4-hin11n2INYfBxcMHb6ruPE8wueRhz5UN19xwtpK48q2XoIdmt7wR97kvfne7PY_Tnx83D4ld9-_vncnF9WwNTbK6pko2W0ionRNtLUIBdRzXeVjrGONdKC1AYt8xqCj3RLRVScEF4TzCx7Bgtd9wuwsqsk58gPZsI3vwrxDQYSLO3ozPOqY5ZYkUDLZdAFZeNUwRYo4F2fVtYVzvWetNOrrMuzAnGD9CPneAfzRCfDCFMEyF1IZzvCSn-3bg8m8ln68YRgoubbBjBEjPVSFGkeCe1KeacXP82h2CzzdK8Zmn2WRbL2fv93gyvyRXBxU5QrGYVNymUr_8_7wUom6rE</recordid><startdate>20240910</startdate><enddate>20240910</enddate><creator>Liang, Tingting</creator><creator>Liu, Jun</creator><creator>Liu, Feila</creator><creator>Su, Xiaohan</creator><creator>Li, Xue</creator><creator>Zeng, Jiao</creator><creator>Chen, Fuli</creator><creator>Wen, Heling</creator><creator>Chen, Yu</creator><creator>Tao, Jianhong</creator><creator>Lei, Qian</creator><creator>Li, Gang</creator><creator>Cheng, Panke</creator><general>American Chemical Society</general><scope>N~.</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-1900-8358</orcidid></search><sort><creationdate>20240910</creationdate><title>Application of Pro-angiogenic Biomaterials in Myocardial Infarction</title><author>Liang, Tingting ; Liu, Jun ; Liu, Feila ; Su, Xiaohan ; Li, Xue ; Zeng, Jiao ; Chen, Fuli ; Wen, Heling ; Chen, Yu ; Tao, Jianhong ; Lei, Qian ; Li, Gang ; Cheng, Panke</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a383t-2867966c8e55bf6a8a0ed2906c8ed33449895a800b3c92af19b25654514f101c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Liang, Tingting</creatorcontrib><creatorcontrib>Liu, Jun</creatorcontrib><creatorcontrib>Liu, Feila</creatorcontrib><creatorcontrib>Su, Xiaohan</creatorcontrib><creatorcontrib>Li, Xue</creatorcontrib><creatorcontrib>Zeng, Jiao</creatorcontrib><creatorcontrib>Chen, Fuli</creatorcontrib><creatorcontrib>Wen, Heling</creatorcontrib><creatorcontrib>Chen, Yu</creatorcontrib><creatorcontrib>Tao, Jianhong</creatorcontrib><creatorcontrib>Lei, Qian</creatorcontrib><creatorcontrib>Li, Gang</creatorcontrib><creatorcontrib>Cheng, Panke</creatorcontrib><collection>American Chemical Society (ACS) Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>ACS omega</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liang, Tingting</au><au>Liu, Jun</au><au>Liu, Feila</au><au>Su, Xiaohan</au><au>Li, Xue</au><au>Zeng, Jiao</au><au>Chen, Fuli</au><au>Wen, Heling</au><au>Chen, Yu</au><au>Tao, Jianhong</au><au>Lei, Qian</au><au>Li, Gang</au><au>Cheng, Panke</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Application of Pro-angiogenic Biomaterials in Myocardial Infarction</atitle><jtitle>ACS omega</jtitle><addtitle>ACS Omega</addtitle><date>2024-09-10</date><risdate>2024</risdate><volume>9</volume><issue>36</issue><spage>37505</spage><epage>37529</epage><pages>37505-37529</pages><issn>2470-1343</issn><eissn>2470-1343</eissn><abstract>Biomaterials have potential applications in the treatment of myocardial infarction (MI). These biomaterials have the ability to mechanically support the ventricular wall and to modulate the inflammatory, metabolic, and local electrophysiological microenvironment. In addition, they can play an equally important role in promoting angiogenesis, which is the primary prerequisite for the treatment of MI. A variety of biomaterials are known to exert pro-angiogenic effects, but the pro-angiogenic mechanisms and functions of different biomaterials are complex and diverse, and have not yet been systematically described. This review will focus on the pro-angiogenesis of biomaterials and systematically describe the mechanisms and functions of different biomaterials in promoting angiogenesis in MI.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>39281944</pmid><doi>10.1021/acsomega.4c04682</doi><tpages>25</tpages><orcidid>https://orcid.org/0000-0002-1900-8358</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2470-1343
ispartof ACS omega, 2024-09, Vol.9 (36), p.37505-37529
issn 2470-1343
2470-1343
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_ee8d3c1c57ab46a28467e81a379a2dfb
source American Chemical Society (ACS) Open Access; PubMed Central
subjects Review
title Application of Pro-angiogenic Biomaterials in Myocardial Infarction
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T17%3A14%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Application%20of%20Pro-angiogenic%20Biomaterials%20in%20Myocardial%20Infarction&rft.jtitle=ACS%20omega&rft.au=Liang,%20Tingting&rft.date=2024-09-10&rft.volume=9&rft.issue=36&rft.spage=37505&rft.epage=37529&rft.pages=37505-37529&rft.issn=2470-1343&rft.eissn=2470-1343&rft_id=info:doi/10.1021/acsomega.4c04682&rft_dat=%3Cproquest_doaj_%3E3106038765%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a383t-2867966c8e55bf6a8a0ed2906c8ed33449895a800b3c92af19b25654514f101c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3106038765&rft_id=info:pmid/39281944&rfr_iscdi=true